Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer

被引：0
|
作者：
Zhao, Q. [1 ]
Deng, L. [2 ,3 ]
Zhang, Y. [2 ,3 ]
Zhou, X. [2 ,3 ]
Li, Y. [2 ,3 ]
Yu, M. [2 ,3 ]
Zhou, L. [2 ,3 ]
Zou, B. [2 ,3 ]
Liu, Y. [2 ,3 ]
Lu, Y. [2 ,3 ]
机构：
[1] Sichuan Univ, West China Sch Med, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Thorac Oncol, Ctr Canc, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1093/annonc/mdw383.42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1242P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Critical points in the management of EGFR-mutated non-small cell lung cancer
    Casaluce, Francesca
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 1748 - 1752
  • [32] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
  • [33] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Shepherd, Annemarie F.
    Preeshagul, Isabel R.
    Shaverdian, Narek
    Wu, Abraham J.
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Rimner, Andreas
    Simone, Charles B., II
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [34] The Management of Brain Metastases in Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
    O'Rourke, Noelle
    Gray, Christine M. N.
    Coyte, Aishah
    Featherstone, Carolyn
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [35] Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
    Cardona, A.
    Arrieta, O.
    Rojas, L.
    Zatarain-Barron, Z.
    Ricaurte, L.
    Ruiz-Patino, A.
    Martin, C.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871
  • [36] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER
    Ianza, A.
    Dicorato, A.
    Guglielmi, A.
    Orlando, V.
    Furlanis, G.
    Curro, F.
    CHEST, 2022, 161 (06) : 333A - 333A
  • [37] Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer
    Calvo, Emiliano
    Lee, Jong-Seok
    Kim, Sang-We
    Moreno, Victor
    deCastro Carpeno, Javier
    Weilert, Doris
    Laus, Gianluca
    Mann, Helen
    Vishwanathan, Karthick
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (08): : 1099 - 1109
  • [38] First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer
    Jeong, Byeong-Ho
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (03)
  • [39] Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis
    Kuiper, Justine L.
    Hendriks, Lizza E.
    van der Wekken, Anthonie J.
    de Langen, Adrianus J.
    Bahce, Idris
    Thunnissen, Erik
    Heideman, Danielle A. M.
    Berk, Yvonne
    Buijs, Ed J. M.
    Speel, Ernst-Jan M.
    Krouwels, Frans H.
    Smit, Hans J. M.
    Groen, Harry J. M.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    LUNG CANCER, 2015, 89 (03) : 255 - 261
  • [40] Leptomeningeal metastases in non-small cell lung cancer patients with EGFR mutations
    Li, Y-S.
    Jiang, B-Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
12345